As a severe complication of systemic sclerosis, PAH is characterized by a high incidence and mortality rate, and GDF15 is significantly elevated in the remodelled pulmonary arteries and serum of systemic sclerosis-PAH patients [114]. Here, GDF15 is linked to systemic sclerosis.